Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.
Clinical trial NCT04775615 · UNKNOWN
Trial details
- NCT number
- NCT04775615
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2021-05-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.